Grimm, Kai
Braaß, Hanna
Sadeghi, Fatemeh
Gelderblom, Mathias
Schulz, Robert
Zittel, Simone https://orcid.org/0000-0002-3767-6376
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (465281508)
Universitätsklinikum Hamburg-Eppendorf (UKE)
Article History
Received: 6 February 2025
Revised: 22 April 2025
Accepted: 20 May 2025
First Online: 3 June 2025
Declarations
:
: Conflicts of interest related to the manuscript: None. Kai Grimm, Hanna Braaß, and Robert Schulz have no relevant financial or non-financial interests to disclose. Fatemeh Sadeghi received grants from the Werner Otto Foundation. Mathias Gelderblom serves on the advisory boards of and received honoraria from Merz Pharma and AbbVie. Simone Zittel received Grants from the German Research Foundation, European Commission, and Damp Foundation and honoraria from Merz Pharma.
: The local ethics committee approved the study (approval number PV5819).
: All participants completed MRI and TMS safety questionnaires when applicable and provided written informed consent in accordance with the Declaration of Helsinki.